Table 4– Health-related quality of life of bronchopulmonary dysplasia (BPD) and control groups
BPDNon-BPDFull-termBPD versus non-BPDBPD versus full-term
Mean difference (95% CI)p-valueMean difference (95% CI)p-value
Subjects n725778
EQ-5D0.84±0.260.88±0.23#0.93±0.13-0.04 (-0.12–0.05)0.413-0.09 (-0.16− -0.03)0.007
EQ-VAS77.54±18.35+79.32±19.00#83.35±12.51-1.78 (-8.39–4.84)0.596-5.80 (-10.86− -0.74)0.028
 Decreased mobility16 (22)7 (12)3 (4)0.1430.001
 Difficulty with self-care9 (12)4 (7)0 (0)0.3040.001
 Problems performing usual activities18 (25)11 (20)6 (8)0.4410.004
 Pain or discomfort15 (21)14 (25)14 (18)0.6140.655
 Anxious or depressed16 (22)11 (20)13 (17)0.7230.411
  • Data are presented as mean±sd or n (%), unless otherwise stated. Bold data indicates statistical significance. p-values were calculated using Chi-squared analysis or Fisher’s exact test if n≤5. EQ-5D: EuroQol five-dimension component index; EQ-VAS: EuroQol visual analogue scale. #: n=56; : n=77; +: n=70.